Thank you, John. First, total revenue for the 3 months ended September 30, 2022, was approximately $13.5 million compared to approximately $8.5 million for the 3 months ended September 30, 2021, an increase of approximately $5 million or 58.9%. This increase in revenue was primarily attributable to an increase in our lending operations. For the third quarter, interest income was approximately $11.5 million compared to approximately $6.1 million for the same period last year, representing an increase of $5.4 million or 89.5%. Origination and modification fees were approximately $1.7 million compared to approximately $1.3 million for the same period last year, representing an increase of approximately $400,000 or 31.6%. For the 3 months ended September 30, 2022, revenue was partially offset of approximately $1.1 million of unrealized losses on investment securities, which John touched on before. There was no such offset in the comparable 2021 period. Total operating costs and expenses for the 3 months ended September 30, 2022, were approximately $8.5 million compared to approximately $4.2 million for the 3 months ended September 30, 2021, an increase approximately $4.3 million. The increase in operating costs and expenses is primarily attributable to the increase in our indebtedness, specifically our unsecured 5-year notes, which has helped finance the growth of our loan portfolio. For the 3 months ended September 30, 2022, interest and amortization of deferred financing cost was approximately $6.0 million compared to approximately $2.6 million for the same period last year, an increase of $3.4 million. The balance of the increase in the operating expenses was primarily attributable to 2 items: first, compensation fees, taxes increased approximately $738,000; and general administrative expenses, which increased by approximately $237,500 over to comparable 2021 amount. For the quarter ended September 30, 2022, we reported an unrealized loss on investment securities of approximately $132,000, reflecting a decrease in the market value of certain securities since June 30, 2022, the prior quarter. For September 30, 2021 period, we reported an unrealized loss on investment securities of approximately $500,000, reflecting the decrease in the market value of such securities since June 30, 2021. Net income attributable to common shareholders for the 3 months ended September 30, 2022, was approximately $4.1 million or $0.11 a share compared to approximately $3.4 million or $0.12 a share for the 3 months ended September 30, 2021. After excluding the unrealized losses on securities available for sale of approximately $1.5 million in the third quarter of 2022, non-GAAP adjusted earnings for the 3 months ended September 30, 2022, was approximately $5.2 million or $0.13 per share compared to approximately $3.4 million or $0.12 per share for the 3 months ended September 30, 2021, an increase of approximately $1.8 million or 53.8%. As John mentioned prior, we believe our adjusted earnings provide a better representation of our core operating performance, and this metric clearly reflects the execution of our strategy to drive value for shareholders. Since this is a non-GAAP figure, I would encourage investors to carefully review the reconciliation to GAAP and descriptions included in our earnings press release. It is also important to note that the unrealized loss reflects just a 1.6% decline in the market value of the company's short-term investments. In contrast, the Barclays Aggregate Bond Index was down 5.6% from the beginning of the quarter through June 30. As discussed last quarter, rising interest rates reduced the value of our note and bond portfolio as investors look for greater yields on term investments. That said, if we hold these investments to maturity, we should recognize the full value of the investments and we reverse the charges back into income. In terms of Sachem's financial condition as of September 30, 2022, compared to December 31, 2021, total assets at September 30, 2022, were approximately $561.8 million compared to approximately $418 million at December 30, 2021, an increase of approximately $143.8 million or 34.4%. The increase in total assets was primarily due to the increase in our mortgage loan portfolio of approximately $156.2 million, an increase in investments in partnerships of approximately $16.5 million, which was offset partially by a decrease in cash, cash equivalents and investment securities of approximately $32.8 million. Total liabilities at September 30, 2022, were approximately $342.5 million compared to $237.9 million at December 31, 2021, an increase of approximately $104.6 million or approximately 44%. This increase was primarily due to increases in the repurchase facility of approximately $24 million and the notes payable, net of deferred financing costs, of approximately $119 million, primarily offset by decreases in the accounts payable and accrued liabilities, including dividends payable, of approximately $3.5 million and a line of credit by approximately $29.6 million and advances from borrowers of approximately $5.1 million. Total shareholders' equity at September 30, 2022, was approximately $219.3 million compared to approximately $180.1 million at December 31, 2021, an increase of approximately $39.2 million. This increase was primarily due to net proceeds of $36.7 million from the sale of common shares through our ATM and our net income attributable to common shareholders of approximately $11.9 million, offset by dividends paid on our Series A preferred stock and common shares of $2.8 million and $9.6 million, respectively, during the quarter. On that note, I'll turn the call back to John Villano.